6-shogaol was understood as a favorable target effect on TNF-α (2AZ5), NF-κβ (1SVC), BDNF(1B8M), and Nrf-2 (5FZN) signaling pathways that play a key role in 3-NPA-induced HD. This evidence concerns the gene NFKB1 and Huntington disease.